IP Library Granted Patent US 12,582,439
Granted Patent B2
US 12,582,439 · App. 16/906,457 · Granted Mar 24, 2026

Transcarotid vascular access sheath

Inventors: Sumaira MacDonald (Sunnyvale, CA); Stewart M. Kume (Sunnyvale, CA)
Assignee: BOSTON SCIENTIFIC SCIMED, INC.
A61B17/3423A61B17/12136A61B17/122
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,582,439
App. No.
16/906,457
Granted
Mar 24, 2026
Kind
B2
Abstract

Methods, devices, and systems establish and facilitate retrograde or reverse flow blood circulation in the region of the carotid artery bifurcation in order to limit or prevent the release of emboli into the cerebral vasculature such as into the internal carotid artery. The methods are particularly useful for interventional procedures, such as stenting and angioplasty, atherectomy performed through a transcarotid approach or transfemoral into the common carotid artery, either using an open surgical technique or using a percutaneous technique, such as a modified Seldinger technique or a micropuncture technique.

Claims (21)

1 . A system for treating a carotid artery, comprising:

an arterial access device wherein the access device includes a distal sheath adapted to be introduced into a carotid artery through a penetration in a wall of the carotid artery, the sheath having a distal end adapted to be introduced into the common carotid artery, a proximal end, and a lumen extending between the distal and proximal ends and communicating with a distal opening and a proximal opening;

a distal sheath tip attached to a distal end of a sheath body, and wherein the distal sheath tip is at least partially formed of a reinforcement material comprising a plurality of support struts that are embedded within a wall of only the distal sheath tip and wherein the support struts each have a proximal end at the distal end of the sheath body and a distal end positioned adjacent a distal end of the sheath tip;

wherein a proximal end of the reinforcing material extends to a position adjacent to a proximal end of the distal sheath tip; and

a stopper member that covers a portion of a distal section of the distal sheath such that a portion of the distal section of the sheath is covered by the stopper member and an exposed portion of the distal section of the distal sheath is exposed, wherein the stopper member, when coupled to the distal sheath, limits insertion of the distal sheath into the carotid artery to the exposed portion and wherein the stopper member is deformable from a first shape to a second shape and wherein the stopper member retains the second shape after deformation until a sufficient external force acts on the stopper member to change its shape, and wherein the second shape includes multiple bends, wherein the stopper member is in a locked position relative to the distal section of the distal sheath, wherein the stopper member includes a series of indents along the length of the sheath stopper such that the indents increase a bendability of the stopper member while maintaining axial strength to allow forward force of the stopper member against an arterial wall.

2 . The system as in claim 1 , wherein the stopper member is removable from the distal section of the distal sheath.

3 . The system as in claim 1 , wherein the reinforcement material comprises at least one of a high durometer polymer a metal.

4 . The system as in claim 1 , wherein the support struts comprise at least one of: a plurality of metal strips, a plurality of high durometer polymer strips, and a plurality of wire loops.

5 . A method for treating a carotid artery, comprising:

positioning an arterial access device having a distal sheath into a common carotid artery through an access location in a neck of a patient, the arterial access device comprising:

a distal sheath adapted to be introduced into a carotid artery through a penetration in a wall of the carotid artery, the sheath having a distal end adapted to be introduced into the common carotid artery, a proximal end, and a lumen extending between the distal and proximal ends and communicating with a distal opening and a proximal opening;

distal sheath tip attached to a distal end of a sheath body, and wherein the distal sheath tip is at least partially formed of a reinforcement material comprising a plurality of support struts that are embedded within a wall of only the distal sheath tip and wherein the support struts each have a proximal end at the distal end of the sheath body and a distal end positioned adjacent a distal end of the sheath tip;

a stopper member that covers a portion of a distal section of the distal sheath such that a portion of the distal section of the sheath is covered by the stopper member and an exposed portion of the distal section of the distal sheath is exposed, wherein the stopper member, when coupled to the distal sheath, limits insertion of the distal sheath into the carotid artery to the exposed portion and wherein the stopper member is deformable from a first shape to a second shape and wherein the stopper member retains the second shape after deformation until a sufficient external force acts on the stopper member to change its shape, and wherein the second shape includes multiple bends, wherein the stopper member is in a locked position relative to the distal section of the distal sheath, wherein the stopper member includes a series of indents along the length of the sheath stopper such that the indents increase a bendability of the stopper member while maintaining axial strength to allow forward force of the stopper member against an arterial wall;

occluding blood flow at an occlusion location of the common carotid artery so as to establish retrograde blood flow through the common carotid artery such that blood flows into the lumen of the arterial access device, wherein the occlusion location is located proximal of the distal opening of the distal sheath so as to form a zone between the occlusion location and the distal opening.

6 . The method of claim 5 , further comprising:

inserting no more than the exposed portion of the sheath into the common carotid artery.

7 . The method of claim 6 , wherein the reinforcement material is located entirely within the exposed portion of the distal sheath.

8 . The method of claim 5 , wherein the zone is a static zone.

9 . The method of claim 5 , wherein occluding blood flow at an occlusion location comprises applying a vascular clamp at the occlusion location.

10 . The method of claim 5 , wherein occluding blood flow at an occlusion location comprises expanding a balloon at the occlusion location.

11 . The method of claim 5 , further comprising making a transcervical incision to expose a region of a common carotid artery at the access location.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2025
From: SILK ROAD MEDICAL, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 070671/0426 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2025
From: MACDONALD, SUMAIRA; KUME, STEWART M.
To: SILK ROAD MEDICAL, INC.
Reel/Frame 070525/0413 →
RELEASE OF SECURITY INTEREST Recorded Sep 17, 2024
From: OXFORD FINANCE, LLC
To: SILK ROAD MEDICAL, INC.
Reel/Frame 068979/0196 →
SECURITY INTEREST Recorded Jul 11, 2023
From: SILK ROAD MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 064252/0197 →
Continuity (2)
Provisional Application 62865016 · Jun 21, 2019
Related Publication 20200397472A1 · Dec 24, 2020
References Cited (130)
US 5727594A · Choksi · 1998 [cited by applicant]
US 6048331A · Tsugita · 2000 [cited by examiner]
US 6152909A · Bagaoisan · 2000 [cited by examiner]
US 6413235B1 · Parodi · 2002 [cited by applicant]
US 6423032B2 · Parodi · 2002 [cited by applicant]
US 6595953B1 · Coppi et al. · 2003 [cited by applicant]
US 6837881B1 · Barbut · 2005 [cited by applicant]
US 6849068B1 · Bagaoisan · 2005 [cited by examiner]
US 7083594B2 · Coppi · 2006 [cited by applicant]
US 8157760B2 · Criado et al. · 2012 [cited by applicant]
US 9126018B1 · Garrison · 2015 [cited by applicant]
US 9241699B1 · Kume et al. · 2016 [cited by applicant]
US 20020183781A1 · Casey · 2002 [cited by examiner]
US 20050154344A1 · Chang · 2005 [cited by applicant]
US 20050154349A1 · Renz et al. · 2005 [cited by applicant]
US 20060106338A1 · Chang · 2006 [cited by applicant]
US 20060200191A1 · Zadno-Azizi · 2006 [cited by examiner]
US 20060210605A1 · Chang · 2006 [cited by examiner]
US 20090018455A1 · Chang · 2009 [cited by applicant]
US 20090024072A1 · Criado et al. · 2009 [cited by applicant]
US 20090088728A1 · Dollar · 2009 [cited by examiner]
US 20090198172A1 · Garrison et al. · 2009 [cited by applicant]
US 20090254166A1 · Chou et al. · 2009 [cited by applicant]
US 20100042118A1 · Garrison et al. · 2010 [cited by applicant]
US 20100185216A1 · Garrison et al. · 2010 [cited by applicant]
US 20100191169A1 · Chang · 2010 [cited by applicant]
US 20100191170A1 · Chang · 2010 [cited by applicant]
US 20100204684A1 · Garrison et al. · 2010 [cited by applicant]
US 20100217276A1 · Garrison et al. · 2010 [cited by applicant]
US 20100228269A1 · Garrison et al. · 2010 [cited by applicant]
US 20100280431A1 · Criado et al. · 2010 [cited by applicant]
US 20110004147A1 · Renati et al. · 2011 [cited by applicant]
US 20110034986A1 · Chou et al. · 2011 [cited by applicant]
US 20110082408A1 · Chang · 2011 [cited by applicant]
US 20110087147A1 · Garrison et al. · 2011 [cited by applicant]
US 20110125131A1 · Chang · 2011 [cited by applicant]
US 20110166496A1 · Criado et al. · 2011 [cited by applicant]
US 20110166497A1 · Criado et al. · 2011 [cited by applicant]
US 20110213459A1 · Garrison et al. · 2011 [cited by applicant]
US 20130172852A1 · Chang · 2013 [cited by applicant]
US 20130197621A1 · Ryan et al. · 2013 [cited by applicant]
US 20140031682A1 · Renati et al. · 2014 [cited by applicant]
US 20140031925A1 · Garrison et al. · 2014 [cited by applicant]
US 20140046346A1 · Hentges et al. · 2014 [cited by applicant]
US 20140058414A1 · Garrison et al. · 2014 [cited by applicant]
US 20140135661A1 · Garrison et al. · 2014 [cited by applicant]
US 20140296769A1 · Hyde et al. · 2014 [cited by applicant]
US 20140296868A1 · Garrison et al. · 2014 [cited by applicant]
US 20140343676A1 · Woodroof · 2014 [cited by applicant]
US 20140371653A1 · Criado et al. · 2014 [cited by applicant]
US 20150025616A1 · Chang · 2015 [cited by applicant]
US 20150080942A1 · Garrison et al. · 2015 [cited by applicant]
US 20150141760A1 · Chou et al. · 2015 [cited by applicant]
US 20150150562A1 · Chang · 2015 [cited by applicant]
US 20150174368A1 · Garrison et al. · 2015 [cited by applicant]
US 20150327843A1 · Garrison · 2015 [cited by applicant]
US 20160128688A1 · Garrison et al. · 2016 [cited by applicant]
US 20160158044A1 · Chou et al. · 2016 [cited by applicant]
US 20160158502A1 · Kume et al. · 2016 [cited by applicant]
US 20160166804A1 · Garrison et al. · 2016 [cited by applicant]
US 20160242764A1 · Garrison et al. · 2016 [cited by applicant]
US 20160271315A1 · Chang · 2016 [cited by applicant]
US 20160271316A1 · Criado et al. · 2016 [cited by applicant]
US 20160279379A1 · Chang · 2016 [cited by applicant]
US 20160296690A1 · Kume et al. · 2016 [cited by applicant]
US 20160317288A1 · Rogers et al. · 2016 [cited by applicant]
US 20170043141A1 · Kume et al. · 2017 [cited by applicant]
US 20170136212A1 · Garrison et al. · 2017 [cited by applicant]
US 20170209260A1 · Garrison et al. · 2017 [cited by applicant]
US 20170296798A1 · Kume · 2017 [cited by examiner]
US 20170312491A1 · Ryan et al. · 2017 [cited by applicant]
US 20170354523A1 · Chou et al. · 2017 [cited by applicant]
US 20170354803A1 · Kume et al. · 2017 [cited by applicant]
US 20170361072A1 · Chou et al. · 2017 [cited by applicant]
US 20170368296A1 · Chang · 2017 [cited by applicant]
US 20180008294A1 · Garrison et al. · 2018 [cited by applicant]
US 20180154063A1 · Criado et al. · 2018 [cited by applicant]
US 20180185614A1 · Garrison et al. · 2018 [cited by applicant]
US 20180235789A1 · Wallace et al. · 2018 [cited by applicant]
US 20180289884A1 · Criado et al. · 2018 [cited by applicant]
US 20190105439A1 · Criado et al. · 2019 [cited by applicant]
US 20190125512A1 · MacDonald et al. · 2019 [cited by applicant]
US 20190150916A1 · Hentges et al. · 2019 [cited by applicant]
US 20190175885A1 · Kume et al. · 2019 [cited by applicant]
US 20190231962A1 · Criado et al. · 2019 [cited by applicant]
US 20190254680A1 · Chang · 2019 [cited by applicant]
US 20190262530A1 · Criado et al. · 2019 [cited by applicant]
US 20190269538A1 · Chou et al. · 2019 [cited by applicant]
US 20190350568A1 · Garrison · 2019 [cited by applicant]
US 20190366070A1 · Kume et al. · 2019 [cited by applicant]
US 20190388654A1 · Chou et al. · 2019 [cited by applicant]
US 20200009406A1 · Garrison et al. · 2020 [cited by applicant]
US 20200015826A1 · Chang · 2020 [cited by applicant]
US 20200016321A1 · Criado et al. · 2020 [cited by applicant]
US 20200038576A1 · Garrison et al. · 2020 [cited by applicant]
US 20200054871A1 · Ryan et al. · 2020 [cited by applicant]
US 20200108221A1 · Chang · 2020 [cited by applicant]
US 20200113587A1 · Garrison et al. · 2020 [cited by applicant]
US 20200170637A1 · Garrison et al. · 2020 [cited by applicant]
US 20200171277A1 · Garrison et al. · 2020 [cited by applicant]
US 20200282127A1 · Garrison et al. · 2020 [cited by applicant]
US 20210145453A1 · Kume · 2021 [cited by applicant]
US 20220378565A1 · Kume et al. · 2022 [cited by applicant]
US 20220401111A1 · Rogers et al. · 2022 [cited by applicant]
Henry et al. (1999) “Carotid stenting with cerebral protection: First clinical experience using the PercuSurge GuardWire System” [cited by applicant]
Ribo et al. (2006). “Transcranial doppler monitoring of transcervical carotid stenting with flow reversal protection: a novel carotid revascularization technique” [cited by applicant]
Stejskal, et al., “Experience of 500 Cases of Neurophysiological Monitoring in Carotid Endarterectomy”, Acta Neurochir, 2007, 149:681-689. [cited by applicant]
U.S. Appl. No. 14/227,585, filed Mar. 27, 2014, US 2014-0296769. [cited by applicant]
U.S. Appl. No. 15/049,637, filed Feb. 22, 2016, US 2016-0242764. [cited by applicant]
U.S. Appl. No. 15/141,060, filed Apr. 28, 2016, US 2016-0317288. [cited by applicant]
U.S. Appl. No. 15/399,638, filed Jan. 5, 2017, US 2017-0209260. [cited by applicant]
U.S. Appl. No. 15/641,966, filed Jul. 5, 2017, US 2017-0296798. [cited by applicant]
U.S. Appl. No. 15/901,502, filed Feb. 21, 2018, US 2018-0235789. [cited by applicant]
U.S. Appl. No. 16/056,208, filed Aug. 6, 2018, US 2019-0175885. [cited by applicant]
U.S. Appl. No. 16/148,849, filed Oct. 1, 2018, US 2019-0269538. [cited by applicant]
U.S. Appl. No. 16/171,784, filed Oct. 26, 2018, US 2019-0125512. [cited by applicant]
U.S. Appl. No. 16/177,716, filed Nov. 1, 2018, US 2019-0150916. [cited by applicant]
U.S. Appl. No. 16/250,825, filed Jan. 17, 2019, US 2019-0350568. [cited by applicant]
U.S. Appl. No. 16/256,229, filed Jan. 24, 2019, US 2019-0254680. [cited by applicant]
U.S. Appl. No. 16/281,311, filed Feb. 21, 2019, US 2019-0388654. [cited by applicant]
U.S. Appl. No. 16/297,348, filed Mar. 8, 2019, US 2020-0038576. [cited by applicant]
U.S. Appl. No. 16/299,524, filed Mar. 12, 2019, US 2019-0366070. [cited by applicant]
U.S. Appl. No. 16/353,492, filed Mar. 14, 2019, US 2020-0009406. [cited by applicant]
U.S. Appl. No. 16/377,663, filed Apr. 8, 2019, US 2019-0231962. [cited by applicant]
U.S. Appl. No. 16/411,543, filed May 14, 2019, US 2020-0108221. [cited by applicant]
U.S. Appl. No. 16/513,030, filed Jul. 16, 2019, US 2020-0170637. [cited by applicant]
U.S. Appl. No. 16/530,783, filed Aug. 2, 2019, US 2020-0054871. [cited by applicant]
U.S. Appl. No. 16/544,083, filed Aug. 19, 2019, US 2020-0171277. [cited by applicant]
U.S. Appl. No. 16/547,042, filed Aug. 21, 2019, US 2020-0113587. [cited by applicant]
U.S. Appl. No. 16/880,594, filed May 21, 2020, US 2020-0282127. [cited by applicant]